BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chini CCS, Peclat TR, Gomez LS, Zeidler JD, Warner GM, Kashyap S, Mazdeh DZ, Hayat F, Migaud ME, Paulus A, Chanan-khan AA, Chini EN. Dihydronicotinamide Riboside Is a Potent NAD+ Precursor Promoting a Pro-Inflammatory Phenotype in Macrophages. Front Immunol 2022;13:840246. [DOI: 10.3389/fimmu.2022.840246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zapata-pérez R, Ginés García-saura A, Scantlebery AM, Schomakers BV, Rabadán-ros R, van Weeghel M, Houtkooper RH, Sánchez-ferrer Á. Biotechnological production of reduced and oxidized NAD+ precursors. Food Research International 2023. [DOI: 10.1016/j.foodres.2023.112560] [Reference Citation Analysis]
2 Lu J, Wang M, Chen Y, Song H, Wen D, Tu J, Guo Y, Liu Z. NAMPT inhibition reduces macrophage inflammation through the NAD+/PARP1 pathway to attenuate liver ischemia-reperfusion injury. Chem Biol Interact 2023;369:110294. [PMID: 36460127 DOI: 10.1016/j.cbi.2022.110294] [Reference Citation Analysis]
3 Nakashima C, Fujiwara-tani R, Mori S, Kishi S, Ohmori H, Fujii K, Mori T, Miyagawa Y, Yamamoto K, Kirita T, Luo Y, Kuniyasu H. An Axis between the Long Non-Coding RNA HOXA11-AS and NQOs Enhances Metastatic Ability in Oral Squamous Cell Carcinoma. IJMS 2022;23:10704. [DOI: 10.3390/ijms231810704] [Reference Citation Analysis]